Skip to main content
. 2018 Jan 29;13(1):e0188551. doi: 10.1371/journal.pone.0188551

Table 1. Participant's clinical background.

group Continuous aerobic training
(n = 15)
Super-circuit training
(n = 14
n (%) n (%)
Pharmacological treatment Beta-blockers 10 (66.7) 8 (57.1)
An angiotensin-converting-enzyme inhibitor 8 (81) 10 (71.4)
Diuretics 3 (24.0) 4 (28.6)
Statins 10 (76.7) 12 (85.7)
Anti-coagulations 5 (33.3) 5 (35.7)
Co-morbidities Diabetes mellitus 5 (33.3) 3 (21.4)
Hypertension 8 (53.3) 8 (57.1)
Obesity 4 (26.7) 3 (21.4)